Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

FOLLOW US: 

March 30, 2020

Bard Hernia Mesh Trials in Litigation Rescheduled for July and September 2020

In light of the coronavirus outbreak, the U.S. District Judge presiding over the Bard hernia mesh litigation decided to push the starting dates for the first two bellwether trials back to July and September 2020.  U.S. District Judge Edmund A. Sargus, who presides over all federal hernia mesh lawsuits against C.R. Bard, issued two case management orders on March 24th announcing the new jury trial dates. Now, the start of the first bellwether trial will begin July 13, 2020 and the second trial will begin September 29. Thousands of other lawsuits and trials across the country have been postponed, as well, due to the COVID-19 pandemic.

Currently, medical manufacturer C.R. Bard faces over 3,500 product liability lawsuits in the federal court system over their hernia mesh implants. Patients across the country claim Bard’s surgical mesh implants were faulty and caused individuals to experience severe complications, some of which required another painful surgery to fix. Specific mesh models named in the hernia mesh lawsuits include Bard’s Ventralight, Ventralex, Perfix, and 3DMax patch designs among others.

Due to the thousands of similar hernia mesh lawsuits all alleging common questions of fact and law, the federal judiciary decided to consolidate the claims as part of a Bard hernia mesh litigation in the Southern District of Ohio. Judge Sargus decided to establish a bellwether process, which sets up a series of early trial dates to see how juries react to certain evidence and testimonies that will be repeated throughout the hernia mesh lawsuits. If a settlement is not reached to resolve the thousands of hernia mesh lawsuits field in the litigation, each case may be remanded back to the courts they were originally filed in for future individual trial dates.

Recent Posts

Truvada Lawsuit Filed for Dangerous Side Effects of Tenofovir HIV Drugs

Allegations brought forward in a recent product liability lawsuit call out Gilead Sciences, Inc. for the dangerous side effects of their tenofovir-based HIV drugs, which include Truvada, Stribild, and Viread. Numerous lawsuits from across the U.S. allege tenofovir HIV drugs cause users to experience severe side effects, including kidney and bone injuries. Last week a […]

Read More
3M Earplug Bellwether Trial Scheduled for April 2021 Over Military Hearing Loss

The judge presiding over all federal 3M military earplug lawsuits announced that the first “bellwether” case in the litigation will go to trial April 5, 2021. This case, like the thousands of others in the litigation, allege 3M’s military earplugs were defective and caused veterans to suffer hearing severe injuries. Currently, over 150,000 earplug injury […]

Read More

Contact Us Today for your free, in-depth case evaluation

We're on Your Side
We're available 24/7
no fees unless you win

Free in-depth 
no obligation case evaluation

ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in California, Montana and Nevada, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, California 92106. 

Consult a doctor on all medical decisions. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. Legal representation is not offered or available in Tennessee. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility.
envelopephone-handsetmap-markerarrow-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram